PHARMA
Mundipharma Launches OxyNorm Injection In China
Mundipharma, a pain-management and drug-delivery company, has launched OxyNorm injections, a product for post-operative pain, in China.
Navidea To Distribute GMST’s Lymphoseek Injection In Taiwan
Navidea Biopharmaceuticals has entered into an agreement with Global Medical Solutions Taiwan to distribute GMST's Lymphoseek® injection in Taiwan.
Tactus Closes First Portion Of Series B Funding Round
Tactus Technology, Inc. has closed the first portion of its Series B funding round with new investors from Asia joining existing investors.
Hepalink To Acquire Scientific Protein Laboratories
Shenzhen Hepalink Pharma is set to acquire Scientific Protein Laboratories, a manufacturer and supplier of active pharmaceutical ingredients.
Alvogen Partially Acquires Lotus Pharma For US$200 Million
Lotus Pharmaceutical has signed a deal with US-based drug maker Alvogen Group Inc, allowing Alvogen to acquire 60 percent of its shares.
Takeda Submits New Drug Application For Fomepizole
Takeda has submitted an NDA to the Japanese Ministry of Health, Labor and Welfare for fomepizole, a treatment for ethylene glycol and methanol poisonings.
Takeda, MMV Partner To Study Anti-Malarial Compounds
Takeda Pharma will collaborate with Medicines for Malaria Venture to study two new anti-malarial compounds.
Chugai Opens Sales Office In China Medical City
Chugai has opened an import, sales and marketing subsidiary in China Medical City.
TaiGen’s Nemonoxacin Receives US FDA Fast Track Designation
TaiGen Biotech's nemonoxacin has received fast track designation and Qualified Infectious Disease Product status by the US FDA.
